Chiyuan Piao

621 total citations
24 papers, 416 citations indexed

About

Chiyuan Piao is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chiyuan Piao has authored 24 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chiyuan Piao's work include Epigenetics and DNA Methylation (9 papers), Cancer-related molecular mechanisms research (9 papers) and Cancer, Lipids, and Metabolism (5 papers). Chiyuan Piao is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), Cancer-related molecular mechanisms research (9 papers) and Cancer, Lipids, and Metabolism (5 papers). Chiyuan Piao collaborates with scholars based in China. Chiyuan Piao's co-authors include Chuize Kong, Xiaolu Cui, Zhe Zhang, Yuanjun Jiang, Xuyong Lin, Bo Zhan, Zhuonan Liu, Xiankui Liu, Xiaojun Man and Yuyan Zhu and has published in prestigious journals such as Cellular and Molecular Life Sciences, Cell Death and Disease and Genomics.

In The Last Decade

Chiyuan Piao

23 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiyuan Piao China 13 310 217 74 55 37 24 416
Guobin Tan China 10 231 0.7× 170 0.8× 72 1.0× 49 0.9× 33 0.9× 18 366
Christoph Wohlkoenig Austria 7 281 0.9× 189 0.9× 65 0.9× 80 1.5× 23 0.6× 9 413
Shouru Zhang China 12 331 1.1× 139 0.6× 64 0.9× 131 2.4× 26 0.7× 18 439
Yinmin Gu China 12 235 0.8× 166 0.8× 53 0.7× 71 1.3× 43 1.2× 25 336
Naïma Maloujahmoum Belgium 7 259 0.8× 215 1.0× 154 2.1× 75 1.4× 19 0.5× 10 405
Zhenbing Lv China 12 373 1.2× 237 1.1× 35 0.5× 66 1.2× 16 0.4× 20 463
Shyamananda Singh Mayengbam India 7 181 0.6× 200 0.9× 33 0.4× 61 1.1× 78 2.1× 8 331
Alicia M. Blessing United States 9 281 0.9× 179 0.8× 69 0.9× 67 1.2× 33 0.9× 10 413

Countries citing papers authored by Chiyuan Piao

Since Specialization
Citations

This map shows the geographic impact of Chiyuan Piao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiyuan Piao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiyuan Piao more than expected).

Fields of papers citing papers by Chiyuan Piao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiyuan Piao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiyuan Piao. The network helps show where Chiyuan Piao may publish in the future.

Co-authorship network of co-authors of Chiyuan Piao

This figure shows the co-authorship network connecting the top 25 collaborators of Chiyuan Piao. A scholar is included among the top collaborators of Chiyuan Piao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiyuan Piao. Chiyuan Piao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Zhuonan, et al.. (2025). METTL14‐mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination. Clinical and Translational Medicine. 15(2). e70232–e70232.
2.
Li, Yuchen, Chiyuan Piao, & Chuize Kong. (2024). Stearoyl CoA desaturase inhibition can effectively induce apoptosis in bladder cancer stem cells. Cancer Cell International. 24(1). 357–357. 1 indexed citations
3.
Peng, Xin, et al.. (2024). Ferroptosis Is Crucial for Cisplatin Induced Sertoli Cell Injury via N6-Methyladenosine Dependent Manner. The World Journal of Men s Health. 42(4). 865–865. 6 indexed citations
4.
5.
Piao, Chiyuan, et al.. (2023). LncRNA SNHG4 promotes prostate cancer cell survival and resistance to enzalutamide through a let-7a/RREB1 positive feedback loop and a ceRNA network. Journal of Experimental & Clinical Cancer Research. 42(1). 209–209. 23 indexed citations
6.
Liu, Zimeng, Bohan Li, Zheng Gong, et al.. (2022). Integrated analysis of transcriptomics, proteomics and metabolomics data reveals the role of SLC39A1 in renal cell carcinoma. Frontiers in Cell and Developmental Biology. 10. 977960–977960. 5 indexed citations
7.
Liu, Zhuonan, Tianshui Sun, Chiyuan Piao, Zhe Zhang, & Chuize Kong. (2022). METTL14-mediated N6-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma. Cell Communication and Signaling. 20(1). 36–36. 29 indexed citations
8.
9.
Liu, Shuangjie, Zhuonan Liu, Chiyuan Piao, et al.. (2022). Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer. Journal of Experimental & Clinical Cancer Research. 41(1). 293–293. 20 indexed citations
10.
Zhang, Xi, et al.. (2022). METTL14 promotes migration and invasion of choroidal melanoma by targeting RUNX2 mRNA via m6A modification. Journal of Cellular and Molecular Medicine. 26(22). 5602–5613. 9 indexed citations
11.
Liu, Xi, Shuangjie Liu, Chiyuan Piao, et al.. (2021). Non‐metabolic function of MTHFD2 activates CDK2 in bladder cancer. Cancer Science. 112(12). 4909–4919. 23 indexed citations
12.
13.
Liu, Zhuonan, Tianshui Sun, Chiyuan Piao, Zhe Zhang, & Chuize Kong. (2021). METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression. Journal of Translational Medicine. 19(1). 209–209. 20 indexed citations
14.
Zhan, Bo, Zhe Zhang, Chiyuan Piao, et al.. (2021). The Sigma‐2 Receptor/TMEM97 Agonist PB28 Suppresses Cell Proliferation and Invasion by Regulating the PI3K‐AKT‐mTOR Signalling Pathway in Renal Cancer. Journal of Cellular and Molecular Medicine. 25(24). 11244–11256. 12 indexed citations
15.
Zhang, Zhe, et al.. (2021). Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma. Frontiers in Oncology. 11. 626858–626858. 4 indexed citations
16.
Piao, Chiyuan, Zhe Zhang, Yuyan Zhu, et al.. (2020). Decreased expression and hypomethylation of HDAC9 lead to poor prognosis and inhibit immune cell infiltration in clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 38(9). 740.e1–740.e9. 6 indexed citations
17.
Zhang, Xiaotong, Chiyuan Piao, Jianbin Bi, et al.. (2019). A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma. Biomedicine & Pharmacotherapy. 118. 109079–109079. 21 indexed citations
18.
Cui, Xiaolu, et al.. (2019). ZNFX1 anti-sense RNA 1 promotes the tumorigenesis of prostate cancer by regulating c-Myc expression via a regulatory network of competing endogenous RNAs. Cellular and Molecular Life Sciences. 77(6). 1135–1152. 17 indexed citations
19.
Man, Xiaojun, Chiyuan Piao, Xuyong Lin, et al.. (2019). USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 259–259. 72 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guobin Tan Breakdown of academic impact, for papers by Christoph Wohlkoenig Breakdown of academic impact, for papers by Shouru Zhang Breakdown of academic impact, for papers by Yinmin Gu Breakdown of academic impact, for papers by Naïma Maloujahmoum Breakdown of academic impact, for papers by Zhenbing Lv Breakdown of academic impact, for papers by Shyamananda Singh Mayengbam Breakdown of academic impact, for papers by Alicia M. Blessing
Rankless by CCL
2026